News | August 02, 2007

OncoLogics Inc. Signs Deal for Developing PBRT System

August 3, 2007 - OncoLogics Inc., a comprehensive radiosurgical and radiation therapy clinic in southwest Louisiana, announced that it has entered into an agreement to purchase a Clinatron-250 proton beam radiation therapy (PBRT) system, still under development, from Still River Systems, reportedly becoming the only center in Louisiana to commit to this technology.

Te Clinatron 250 PBRT System is said to be a practical, cost-efficient, single-room PBRT system scaled for use at most cancer centers. The heart of the Clinatron 250 System will be a compact, superconducting high field magnet which directs a proton beam toward a precisely defined isocenter.

Included in the Clinatron 250 PBRT System will be a cyclotron, the proton beam delivery system, a treatment couch with pendant control, a radiographic patient positioning system, proton beam treatment planning, and a link to a treatment record and verify system.

Currently, five U.S. health care facilities have large-scale proton beam Radiation therapy systems which weigh more than 440,000 pounds, require almost 100,000 square feet of space and carry a price tag upward of $150 million for the equipment and building. A group of physicists and scientists from MIT and other academic proton research facilities have spent years developing a smaller, more economical cyclotron that can produce and deliver protons for Radiation therapy. To date, nine centers have committed to purchasing this new technology.

For more information: and

Related Content

Feature | Proton Therapy | October 04, 2018 | By Adam Conner-Simons
Investigating inside the human body often requires cutting open a patient or swallowing long tubes with built-in...
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Videos | Proton Therapy | August 10, 2018
A discussion with Matthew Freeman, Ph.D., scientist at Los Alamos National Laboratory, New Mexico.
IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan
News | Proton Therapy | July 30, 2018
IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Proton Treatment System
Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis
The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional and...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...